anxiety

shutterstock_177126911

Introduction

Anxiety is something we can all relate to. For the most part, anxiety represents a healthy and adaptive physiological response to feared stimuli, preparing your body to respond accordingly. Perfect if you a™re being chased by a bear. However, it can be problematic if those feared stimuli are benign, no longer present, or constitute persistent worries about the future.

At it™s most debilitating, anxiety can be classified into a range of psychiatric diagnoses. The most common of these is generalised anxiety disorder (GAD), which has an estimated lifetime prevalence in the UK of between 4-7%. GAD is characterised by a range of physical symptoms such as muscle tension, poor concentration and disturbed sleep, as well as psychological symptoms such as ongoing and uncontrollable worry. Diagnoses such as panic disorder, social anxiety disorder and phobias all feature anxiety as a primary symptom. In total, anxiety-related difficulties have been estimated to affect as many as 18% of a US-based adult population over a 12-month period.

Though previously categorised as anxiety disorders, both obsessive compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are increasingly being understood as separate diagnoses, but again with anxiety as a common symptom.

What we know already

People with long-term physical health conditions are more prone to experience anxiety as a result. For example, it is estimated that people with Chronic Obstructive Pulmonary Disease (COPD) are up to 10 times more likely to receive a diagnosis of panic disorder than the general population. This, in turn, has considerable implications on healthcare expenditure.

Psychological treatments such a cognitive-behavioural therapy (CBT) have been widely researched and shown to be effective across a range of anxiety disorders. In the case of specific phobias, these techniques can elicit significant improvement in just one session. However, improvement rates are lower across other anxiety disorders.

In England, the National Institute for Health and Care Excellence (NICE) recommends CBT as the first line treatment of anxiety disorders. Pharmacotherapy, such as Sertraline, can also be beneficial, and is recommended as an adjunct to CBT where the person’™s difficulties are more severe.

Areas of uncertainty

Anxiety has been conceptualised in many ways, which in many ways have shaped the range of treatments available. This proliferation of cognitive, developmental, information-processing, neurochemical and other models of understanding anxiety can create a confusing picture. Similarly, whilst there is a clear hereditary component to anxiety, the precise nature is not yet clear.

Whilst psychological and pharmacological treatments can be effective for many, there is still work to be done in identifying the mechanisms of change and improving outcomes.

What’s in the pipeline?

Historically, research into anxiety disorders focused more heavily on adult populations. However, with the recent emergence of disciplines such as paediatric psychology, there is a greater emphasis on tackling anxiety difficulties at a younger age.

As our understanding of genetics improves, it is likely that we will discover more about the role of heritability in anxiety.

Perhaps, most importantly, given the effectiveness of treatments for anxiety, we should aim to reduce stigma and other barriers to access, to enable earlier intervention and better recovery.

References

Antony, M. M., and Stein, M. B. (2009). Oxford handbook of anxiety and related disorders. Oxford University Press. [Publisher]

Hoge, E. A., Ivkovic, A. and Fricchione, G. L. (2012). Generalized anxiety disorder: diagnosis and treatment. BMJ, 345. [Abstract]

Kesller, R. C., Ciu, W. T., Deler, O. and Walters, E. E. (2005). Prevalence, Severity, and Comorbidity of Twelve-month DSM-IV Disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 62, 617-627. [Abstract]

Naylor, C., Parsonage, M., McDaid, D., Knapp, M., Fossey, M. and Galea, A. (2012) Long-term conditions and mental health: the cost of co-morbidities. The King’s Fund, London, UK. [PDF]

Acknowledgement

Written by: Patrick Kennedy-Williams
Reviewed by:
Last updated: Sep 2015
Review due: Sep 2016

Our anxiety Blogs

Does targeting attention and interpretation patterns reduce symptoms of youth anxiety and depression? #ActiveIngredientsMH

asher-legg-MiintsWweZI-unsplash square

Alice Potter summarises a Wellcome Trust funded active ingredients review, which looks at how promoting helpful attention and interpretation patterns may reduce anxiety and depression in young people.

[read the full story...]

Psychological interventions for youth depression and anxiety can improve emotion regulation skills #ActiveIngredientsMH

fabian-centeno-Hkavt2MAOEc-unsplash

In her debut blog, Ariadna Albajara Saenz summarises a recent active ingredients review, which finds that psychological interventions for youth anxiety & depression can improve emotion regulation skills.

[read the full story...]

Psychoeducation for perinatal depression and anxiety in young people #ActiveIngredientsMH

Mother,Holding,Baby,Smiling,To,Camera.,Real,Life,Authentic,Casual

In their debut blog, Wezi Mhango & Darya Gaysina explore psychoeducation as an active ingredient that might help young people who are affected by perinatal anxiety or depression.

[read the full story...]

Family support and parenting interventions for youth anxiety and depression in low and middle income countries #ActiveIngredientsMH

Happy,Indian,Family,Having,Fun,Outdoor,-,Hindu,Parents,Laughing

In their debut blog, Zill-e-Huma & colleagues explore a systematic review finding family interventions beneficial for child anxiety and depression in low and middle income countries.

[read the full story...]

Why doesn’t parent involvement help treat children with anxiety?

eye-for-ebony-zQQ6Y5_RtHE-unsplash

In her debut blog, Jeanne Wolstencroft summarises a systematic review finding that parental involvement in therapy doesn’t help treat children with anxiety.

[read the full story...]

Omega-3 supplements for depression and anxiety #ActiveIngredientsMH

Animal,And,Vegetable,Sources,Of,Omega-3,Acids,As,Salmon,,Avocado,

Ashlee Negrone summarises a systematic review and meta-analysis on omega-3 supplements for depression and anxiety in adults, and briefly introduces their Active Ingredients project on omega-3 for youth depression and anxiety.

[read the full story...]

Virtual reality for mental health: are there any freely available apps that show promise?

Featured

Imogen Bell summarises a recent review of virtual reality experiences as tools to support mental health therapy, which finds some freely available applications that may show promise for mental health.

[read the full story...]

Internet-based psychotherapy may be cost-effective for anxiety and depression

Crisis,Hotline.,Top,View,Of,Woman,In,Need,Of,Psychological

Ally Canaway blogs a systematic review which finds evidence of internet-based psychological interventions being cost-effective for depression and anxiety.

[read the full story...]

Metacognitive therapy for depressive symptoms in cardiac patients: new findings from the PATHWAY trial

Human brain creativity vs logic chaos and order a continuous line drawing concept, organised vs disorganised left and right brain hemispheres as a chaos theory metaphor, one line vector illustration

Lydia Poole reviews a recent randomised controlled trial evaluating group metacognitive therapy for depression and anxiety in cardiac patients.

[read the full story...]

‘Did not attend’: what are the barriers to attending initial psychotherapy appointments?

Featured

Laurence Palfreyman explores a mixed methods systematic review, which brings together research from across the world looking at why people fail to attend their first psychotherapy appointment.

[read the full story...]